Mitotic genome-bookmarking by nuclear hormone receptors: A novel dimension in epigenetic reprogramming and disease assessment
Molecular and Cellular Endocrinology · 2023-12 · 578 · 112069
DOI: 10.1016/j.mce.2023.112069 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Molecular and Cellular Endocrinology, 2023-12. Verfasst von Sheeba Rizvi und 3 weiteren Autor:innen. Beteiligte Einrichtung: Special Centre for Molecular Medicine, Jawaharlal Nehru University, New Delhi, 110067, India. Hauptthemen laut MEDLINE: Mitosis, Epigenesis, Genetic, Receptors, Cytoplasmic and Nuclear, Disease. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 79 Literaturangaben. Gefördert von: Department of Biotechnology, Ministry of Science and Technology, India, Indian Council of Medical Research.
Abstract (Originalsprache)
Arrival of multi-colored fluorescent proteins and advances in live cell imaging has immensely contributed to our understanding of intracellular trafficking of nuclear receptors and their roles in gene regulatory functions. These regulatory events need to be faithfully propagated from progenitor to progeny cells. This is corroborated by multiple converging mechanisms that include histone modifications and lately, the phenomenon of 'mitotic genome-bookmarking' by specific transcription factors. This phenomenon refers to the retention and feed-forward transmission of progenitor's architectural blueprint of active transcription status which is silenced and preserved during mitosis. Upon mitotic exit, this phenomenon ensures accurate reactivation of transcriptome, proteome, cellular traits and phenotypes in the progeny cells. In addition to diverse modes of genome-bookmarking by nuclear receptors, a correlation between disease-associated receptor polymorphism and disruption of this phenomenon is apparent. However, breakthrough technologies shall reveal finer details of this phenomenon to help achieve normalcy in receptor-specific diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Special Centre for Molecular Medicine, Jawaharlal Nehru University, New Delhi, 110067, India.
- Special Centre for Molecular Medicine, Jawaharlal Nehru University, New Delhi, 110067, India. Electronic address: rktyagi@yahoo.com.
Förderung
- Department of Biotechnology, Ministry of Science and Technology, India
- Indian Council of Medical Research
Zitieren
APA
Rizvi, S., Chhabra, A., Tripathi, A., & Tyagi, R. K. (2023). Mitotic genome-bookmarking by nuclear hormone receptors: A novel dimension in epigenetic reprogramming and disease assessment. Molecular and Cellular Endocrinology, 578, 112069. https://doi.org/10.1016/j.mce.2023.112069
Vancouver
Rizvi S, Chhabra A, Tripathi A, Tyagi RK. Mitotic genome-bookmarking by nuclear hormone receptors: A novel dimension in epigenetic reprogramming and disease assessment. Molecular and Cellular Endocrinology. 2023;578:112069. doi:10.1016/j.mce.2023.112069
BibTeX
@article{Rizvi2023,
author = {Rizvi, Sheeba and Chhabra, Ayushi and Tripathi, Anjali and Tyagi, Rakesh K},
title = {Mitotic genome-bookmarking by nuclear hormone receptors: A novel dimension in epigenetic reprogramming and disease assessment},
journal = {Molecular and Cellular Endocrinology},
year = {2023},
volume = {578},
pages = {112069},
doi = {10.1016/j.mce.2023.112069}
}
EUVIMED